<DOC>
	<DOCNO>NCT01490151</DOCNO>
	<brief_summary>The purpose study evaluate treat-to-range automated insulin management system use continuous glucose monitoring ( CGM ) subcutaneous insulin pump infusion individual type 1 diabetes .</brief_summary>
	<brief_title>Medtronic Treat Range ( TTR ) Closed-Loop Control</brief_title>
	<detailed_description>The purpose study demonstrate safety efficacy closed-loop `` treat-to-range '' ( TTR ) system inpatient clinical research center set . The TTR system effect insulin delivery glucose project specify target range . These initial study assess safety algorithm ( mathematical equation ) extreme condition miss meal insulin bolus meal over-insulinization . This `` hybrid '' system , allow research team deliver insulin boluses manually TTR controller become active blood glucose level project specified range .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Nutrition Disorders</mesh_term>
	<criteria>1 . Clinical diagnosis type 1 diabetes use daily insulin therapy least one year . 2 . Age 15 year less 30 year old . 3 . HbA1c &lt; 10 % . 4 . Subject use downloadable insulin pump least 3 month . 5 . Parent/guardian subject understand study protocol agree comply . 6 . Subject comprehends write English . 7 . Subject home computer email access . 8 . For female , subject intend become pregnant study . 9 . No expectation subject move area clinical center study . 10 . Informed Consent Form sign subject guardian . 11 . Subjects severe hypoglycemic event describe seizure , loss consciousness require emergency department visit hospitalization within 6 month enrollment . 1 . Asthma treat systemic inhaled corticosteroid last 6 month ; Subject take oral injectable corticosteroid within last 30 day ; Current use oral/inhaled Glucocorticoids 2 . Cystic fibrosis 3 . Inpatient psychiatric treatment past 6 month either subject subject 's primary care giver ( i.e. , parent guardian ) 4 . Use noninsulin medication may affect blood glucose ( eg Symlin ) , 5 . Systolic blood pressure &gt; 140 screening ; Diastolic blood pressure &gt; 90 screen 6 . History seizure loss consciousness last 6 month . 7 . Adhesive allergy ; Active skin condition would affect sensor placement 8 . History heart disease 9 . Active Graves disease ; 10 . Currently beta blocker medication ; 11 . Unwilling unable follow protocol ; 12 . History diagnose medical eating disorder ; 13 . History known illicit drug abuse prescription drug abuse ; 14 . History current alcohol abuse ; 15 . History visual impairment would allow subject participate 16 . Currently participate investigational study ( drug device ) ; 17 . Other major illness judgment investigator might interfere completion protocol : Adequately treat thyroid disease celiac disease exclude subject enrollment</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Hormone</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Mellitus</keyword>
	<keyword>Type 1</keyword>
	<keyword>Immune</keyword>
	<keyword>Metabolic disorder</keyword>
</DOC>